AJDRAJNR - American Journal of Neuroradiology

Published ahead of print on September 10, 2008
doi: 10.3174/ajnr.A1236

This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Online Table
Right arrow All Versions of this Article:
ajnr.A1236v1
29/10/1918    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Burns, T.C.
Right arrow Articles by Qureshi, A.I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Burns, T.C.
Right arrow Articles by Qureshi, A.I.

INTERVENTIONAL

Endovascular Interventions following Intravenous Thrombolysis May Improve Survival and Recovery in Patients with Acute Ischemic Stroke: A Case-Control Study

T.C. Burnsa, G.J. Rodrigueza, S. Patela, H.M. Husseina, A.L. Georgiadisa, K. Lakshminarayana and A.I. Qureshia

a From the Zeenat Quereshi Stroke Research Center, University of Minnesota, Minneapolis, Minn

Please address correspondence to Gustavo J. Rodriguez, MD, Zeenat Quereshi Stroke Research Center, University of Minnesota, 12-100 PWB, 516 Delaware St SE, Minneapolis, MN 55455; e-mail: rodri218{at}umn.edu

BACKGROUND AND PURPOSE: Since the introduction of recombinant tissue plasminogen activator (rtPA) into clinical practice in the mid 1990s, no adjunctive treatment has further improved clinical outcomes in patients with ischemic stroke. The safety, feasibility, and efficacy of combining intravenous (IV) rtPA with endovascular interventions has been described; however, no direct comparative study has yet established whether endovascular interventions after IV rtPA are superior to IV rtPA alone. A retrospective case-control study was designed to address this issue.

MATERIALS AND METHODS: Between 2003 and 2006, 33 consecutive patients with acute ischemic stroke and National Institutes of Health Stroke Scale (NIHSS) scores ≥10 were treated with IV rtPA in combination with endovascular interventions (IV plus intervention) at a tertiary care facility. Outcomes were compared with a control cohort of 30 consecutive patients treated with IV rtPA (IV only) at a comparable facility where endovascular interventions were not available.

RESULTS: Baseline parameters were similar between the 2 groups. We found that the IV-plus-intervention group experienced significantly lower mortality at 90 days (12.1% versus 40.0%, P = .019) with a significantly greater improvement in NIHSS scores by the time of discharge or follow-up (P = .025). In the IV-plus-intervention group, patients with admission NIHSS scores between 10 and 15 and patients ≤80 years of age showed the greatest improvement, with a significant change of the NIHSS scores from admission (P = .00015 and P = .013, respectively).

CONCLUSIONS: In this small case-control study of patients with acute ischemic stroke and admission NIHSS scores ≥10, there was a suggestion of incremental clinical benefit among patients receiving endovascular interventions following standard administration of IV rtPA.




This article has been cited by other articles:


Home page
Am. J. Neuroradiol.Home page
R.G. Nogueira, A.J. Yoo, F.S. Buonanno, and J.A. Hirsch
Endovascular Approaches to Acute Stroke, Part 2: A Comprehensive Review of Studies and Trials
AJNR Am. J. Neuroradiol., May 1, 2009; 30(5): 859 - 875.
[Abstract] [Full Text] [PDF]